Talcum Powder Litigation Report
Hot on the heels of separate $72 million and $55 million verdicts entered against Johnson & Johnson defendants, HarrisMartin has launched this Talcum Powder Litigation Report, an online-only resource dedicated solely to news on talc-based powder ovarian cancer claims.
SEARCH THE ARCHIVES
Issue #02, May 2016
Imerys Talc America Co. has opposed a talc-based powder plaintiff’s request to perform destructive testing on tissue samples, saying that allowing such testing would be prejudicial and unacceptable.
The 8th Circuit U.S. Court of Appeals has issued a briefing schedule in the defendants’ appeal of an order dismissing a talc-based powder lawsuit, according to documents recently filed with the federal appellate court.
A California resident has filed a wrongful death action in state court, contending that his wife’s use of talc-based powder products caused her to develop ovarian cancer.
For the second time in two months, a Missouri state court jury has found for the plaintiffs in a talc-based powder exposure trial, awarding $55 million to a woman who contended that she developed endometrioid cancer as a result of using Johnson & Johnson’s product, HarrisMartin Publishing was the first to report.
Issue #01, April 2016
Johnson & Johnson Defendants Oppose Motion for Extension on Trial Picks, to Add Plaintiffs to Petition
Defendants involved in a multi-plaintiff talc-based powder exposure suit have opposed a recent motion by the plaintiffs to add more parties to the petition, saying that the proposed parties are not Missouri residents, did not purchase the allegedly harmful products in the state, and were not diagnosed with ovarian cancer in Missouri.
Missouri Court Allows Plaintiffs Leave to File First Amended Complaint to Add 12 Plaintiffs Over Defense Objections
A Missouri state court has issued an order allowing the current plaintiffs in a multi-plaintiff suit to add additional party plaintiffs bringing allegations that use of talc-based body powder products caused them to develop ovarian cancer.
Johnson & Johnson, Imerys Talc Move for Directed Verdict at Conclusion of Plaintiffs’ Evidence in Talc-Based Powder Trial
Johnson & Johnson and Imerys Talc America Inc. have moved for a directed verdict at the close of the plaintiffs’ evidence in a talcum powder ovarian cancer trial, according to the court’s online docket.
Johnson & Johnson, Johnson & Johnson Consumer Inc., and Imerys Talc America Inc. have filed a notice of appeal to the 8th Circuit U.S. Court of Appeals, indicating that they intend to contest a federal court order dismissing without prejudice a talc-based powder suit over their objections.
The eighth day of trial has begun in an action in which a Missouri woman contends that her ovarian cancer was caused by exposure to talc in powder-based personal hygiene products, according to the state court’s online docket.
In a recent complaint, a Washington D.C. resident says her use of Johnson & Johnson’s Baby Powder and Shower to Shower has caused her to develop ovarian cancer and that the company ignored various studies evincing the products’ carcinogenic risks.